Navigating a GSD IV Diagnosis: A Guide for Patients and Families
Last updated:
Glycogen Storage Disease Type IV (GSD IV) is a rare genetic disorder caused by GBE1 gene mutations. It exists on a spectrum, affecting the liver in infants or the nerves and muscles in adults (APBD). Patients require a specialized, multisystemic care team for proper management.
Key Takeaways
- • GSD IV is a highly variable genetic disorder that can present anywhere from infancy to middle adulthood.
- • The disease is multisystemic and can affect the liver, heart, muscles, and nervous system.
- • GSD IV and Adult Polyglucosan Body Disease (APBD) are caused by mutations in the GBE1 gene.
- • Treatment is highly individualized and may include dietary changes, experimental therapies, or liver transplantation.
- • Patients need a coordinated medical team led by a metabolic genetics specialist to manage their care.
Glycogen Storage Disease Type IV (GSD IV), sometimes called Andersen disease or Adult Polyglucosan Body Disease (APBD), is an extremely rare genetic metabolic disorder. It is estimated to occur in about 1 in 600,000 to 1 in 960,000 live births [1][2].
If you or your child have just been diagnosed, it is completely normal to feel overwhelmed, scared, and confused. The medical terminology can seem like a foreign language, and because the disease is so rare, you might find that you are explaining it to some of your local doctors.
This guide is designed to help you understand the diagnosis, make sense of complex medical terms, and prepare for productive discussions with your care team.
Three Stabilizing Facts You Should Know Now
- It is a Spectrum: GSD IV is not one single disease that looks the same in everyone. It operates on a “continuum.” Some forms appear before birth, some primarily affect the liver in childhood, and others (like APBD) only appear in middle adulthood affecting the nerves and muscles [3]. You will not experience every symptom associated with this disease.
- It is Multisystemic: Because the body stores glycogen in many different tissues, GSD IV can affect the liver, heart, muscles, and nervous system [4]. You will need a coordinated team of specialists to manage it.
- You Are Not Alone: While rare, there is a dedicated community of researchers, metabolic specialists, and patient advocacy groups working on this disease. You will need to find a metabolic expert, but you can build a team to support you.
Navigate the Guide
Please use the links below to explore the specific areas of GSD IV that matter most to you right now:
- The Science of GSD IV: Biology & Genetics: Learn about the GBE1 gene, polyglucosan bodies, and why this disease happens.
- The Clinical Continuum: Symptoms by Age: Understand the different ways the disease can present in infants, children, and adults.
- Diagnosis & Pathology Reports: Learn how to translate the complex language in your biopsy and lab reports.
- Standard of Care and Treatments: Discover the role of liver transplant, dietary management, and experimental therapies.
- Building Your Care Team: Find out which specialists you need and how to monitor your health over time.
Frequently Asked Questions
What is Glycogen Storage Disease Type IV (GSD IV)?
Does GSD IV affect everyone the same way?
What causes GSD IV?
What specialists do I need on my GSD IV care team?
What are the treatment options for GSD IV?
Questions for Your Doctor
- • How much experience does this clinic have treating patients with GBE1 mutations?
- • Can you help connect us with a metabolic genetics center that specializes in rare glycogen storage diseases?
- • Who will act as the 'quarterback' for my or my child's care, coordinating between the liver, heart, and nerve specialists?
- • What immediate next steps or baseline scans do we need to schedule this month?
Questions for You
- • What were the first symptoms that led to this diagnosis, and how have they changed?
- • Do I have copies of the genetic testing and pathology reports saved in a safe, accessible place?
- • Who in my life can serve as a support person to attend appointments and help me take notes?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Severe neuromuscular forms of glycogen storage disease type IV: Histological, clinical, biochemical, and molecular findings in a large French case series.
Lefèvre CR, Collardeau-Frachon S, Streichenberger N, et al.
Journal of inherited metabolic disease 2024; (47(2)):255-269 doi:10.1002/jimd.12692.
PMID: 38012812 - 2
Clinical phenotype and trio whole exome sequencing data from a patient with glycogen storage disease IV in Indonesia.
Harsono IW, Ariani Y, Benyamin B, et al.
Data in brief 2025; (58()):111231 doi:10.1016/j.dib.2024.111231.
PMID: 39840231 - 3
A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum.
Kiely BT, Koch RL, Flores L, et al.
Frontiers in genetics 2022; (13()):992406 doi:10.3389/fgene.2022.992406.
PMID: 36176296 - 4
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.
Koch RL, Soler-Alfonso C, Kiely BT, et al.
Molecular genetics and metabolism 2023; (138(3)):107525 doi:10.1016/j.ymgme.2023.107525.
PMID: 36796138
This guide is for informational purposes only and does not replace professional medical advice. Always consult your metabolic specialist or care team about your specific GSD IV diagnosis and treatment options.
Stay up to date
Get notified when new research about Glycogen Storage Disease Type IV is published.
No spam. Unsubscribe anytime.